Immunogenicity, Tolerability, and Safety of BA.1-Adapted BNT162b2 Vaccine in 18- to 55-Year-Olds Previously Vaccinated with BNT162b2 or Who Were COVID-19 Vaccine-Naive. - Fitz-Patrick, David; Sahgal, Omair; Fouché, Leon F.; Mitha, Essack; Malahleha, Mookho; Gayed, Juleen; Keep, Georgina; Zhang, Ying; Modjarrad, Kayvon; Belanger, Todd; Xu, Xia; Cooper, David; et al. (Infectious Diseases & Therapy, 2026)